Clinical trial
Nalrexone Facilitated Discontinuation of Buprenorphine
NCT01895036 is registered in ClinicalTrials.gov with New York State Psychiatric Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Nalrexone Facilitated Discontinuation of Buprenorphine
- Lead sponsor
- New York State Psychiatric Institute
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- February 28, 2011
- Completion date
- September 30, 2013
- Enrollment
- 6 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
stable opioid dependence